Heterogeneity of Colorectal Cancer (CRC) in reference to KRAS proto-oncogene utilizing WAVE technology

BACKGROUND: New drugs targeting specific genes required for unregulated growth and metastases have improved survival rates for patients with metastatic colorectal cancer. Resistance to monoclonal antibodies specific for the epidermal growth factor receptor (EGFR) has been attributed to the presence...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Perez, K, Walsh, R, Brilliant, K, Noble, L, Yakerivich, E, Breese, V, Jackson, C, Chatterjee, D, Pricolo, V, Roth, L, Shah, N, Cataldo, T, Safran, H, Hixson, D, Quesenberry, P
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4015467/
https://ncbi.nlm.nih.gov/pubmed/23528430
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.yexmp.2013.01.004
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars